XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plan - Stock-Based Compensation Expense and Common Stock Warrants (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Award Activity

A summary of the stock option activity for the three months ended March 31, 2023 is as follows:

 

   Number of
Stock
Options
   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Life
   Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2022   1,399,252   $2.40    7.79   $928 
Granted   304,325   $3.40    -   $- 
Exercised   (3,547)  $1.52    -   $- 
Forfeited   (25,000)  $1.82    -   $- 
Expired   -   $-    -   $- 
Outstanding as of March 31, 2023   1,675,030   $2.59    7.95   $2,131 
Exercisable as of March 31, 2023   743,247   $1.92    6.04   $1,478 
Vested and expected to vest as of March 31, 2023   1,675,030   $2.59    7.95   $2,131 
Schedule of Estimate Fair Value of Stock Options

For the three months ended March 31, 2023, and 2022, the Company utilized the Black-Scholes option-pricing model for estimating the fair value of the stock option granted. The Company estimated the fair value of each option grant on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:

   Three Months Ended March 31, 
   2023    2022 
Expected Volatility   99.49% – 103.76%    41.66% – 42.13%
Expected term (years)   6.0210.0     6.44 
Risk-free interest rate   3.51% – 4.28%    0.62% – 1.00%
Dividend rate   %    %
Schedule of Stock Based Compensation Expense

The following table summarizes the components of stock-based compensation expense recognized in the Company’s Condensed Statements of Operations and Comprehensive Loss during the three months ended March 31, 2023, and 2022 (in thousands):

 

   2023   2022 
  Three Months Ended 
   March 31, 
   2023   2022 
Research and development  $42   $45 
General and administrative   202    123 
Total stock-based compensation expense  $244   $168 
Schedule of Warrant Activity

The following is a summary of the common stock warrant activity during the three months ended March 31, 2023.

   Shares
Issuable
Upon Exercise
of Outstanding
Warrants
   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Life
   Aggregate
Intrinsic Value
(In thousands)
 
Outstanding as of December 31, 2022   2,786,995   $10.80    3.67   $30,100 
Issued   -   $-    -   $- 
Exercised   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding as of March 31, 2023   2,786,995   $10.80    3.42   $30,100